Breast cancer and fertility: can I become a mother after cancer?

Post Contents

19 October is World Breast Cancer Day. Breast cancer is one of the tumours whose incidence has increased, and it is appearing at an increasingly younger age. One in eight women will develop this type of cancer during her lifetime.

Fortunately, early diagnosis and current treatments have achieved very favourable cure rates, with survival above 80%. This makes breast cancer one of the tumours with the highest survival rates.

At Clínica Fertia, we wanted to prepare an informative post on cancer and fertility, which we hope will answer some of the most common questions. We believe it is important for women diagnosed with cancer to know that treatment can affect their fertility, but that there are methods to preserve it so that they can become mothers in the future.

When the diagnosis comes during a woman’s fertile years, many dreams and plans are put on hold, as the passage of time and the treatments themselves can reduce her ability to become a mother.

Infertility is a problem for young patients diagnosed with breast cancer; most patients receive no information about the changes that will occur in their reproductive capacity (their ability to have children).

A diagnosis of early-stage breast cancer in a young woman with good survival prospects raises questions about her reproductive future. It is possible to undergo fertility preservation before starting cancer treatment, by means of controlled ovarian stimulation aimed at vitrifying eggs or embryos so that, once the disease has been overcome, the woman can have children with her own gametes.

Effects of breast cancer treatments on fertility

There is evidence that the chemotherapy treatments given for breast cancer have a negative impact on fertility. They can cause:

  • A natural decrease in the number of eggs and the arrest of their maturation. The number of eggs is determined at birth and decreases throughout life with each menstrual cycle; no new ones are produced. This loss of functional eggs depends on factors such as age at the time of the illness, the type of cancer, the medical treatment used, the dose and the number of cycles.
  • A decrease in egg quality, even if the patient does not lose ovarian function.
  • Premature ovarian failure, which, in addition to the end of reproductive and hormonal function, brings other symptoms derived from the latter, such as hot flushes.

How can ovarian function be protected from the toxic effects of chemotherapy?

Pharmacological protection of the ovary during chemotherapy can be achieved by administering gonadotropin-releasing hormone (GnRH) analogues in order to keep the ovaries at rest. These are long-acting hormonal medicines that can be used to induce menopause in a woman for a short time. This is known as ovarian suppression. The aim of this treatment is to make the ovaries stop working during cancer treatment to help protect them from its harmful effects. It is hoped that reducing ovarian activity during treatment will reduce the number of eggs affected, so that women could resume normal menstrual cycles after treatment. However, studies are not clear about the effects of this treatment as a way of preserving fertility. Experts do not recommend using ovarian suppression instead of cryopreservation or other proven methods of fertility preservation.

Fertility preservation methods

How can fertility be preserved?

When a patient diagnosed with cancer comes to us to preserve her fertility, we analyse the best options for preserving her gametes without affecting the course of her disease.

In women, the most commonly used techniques are:

  • Embryo cryopreservation is the most successful method of fertility preservation. It is also called in vitro fertilisation. An ovarian stimulation protocol producing the smallest possible rise in oestrogen is carried out. The eggs are retrieved and fertilised with sperm in a laboratory. The resulting embryos are frozen until later.
  • Oocyte vitrification, which consists of cryopreservation – direct immersion in liquid nitrogen at a temperature of -196 °C – of the mature eggs obtained after ovarian stimulation, so that they can be used once the disease has been overcome with the same quality they had when they were stored.
  • Ovarian tissue cryopreservation, which consists of removing part of the ovarian tissue (rich in primordial follicles) by laparoscopic surgery for later autotransplantation. This technique is used in cases that require chemotherapy to start immediately (with no time for ovarian stimulation), in women for whom ovarian stimulation would not be recommended, or in prepubertal girls (who have not yet had their first period). It is still experimental, although there have already been live births after this technique.

At Clínica Fertia, we are proud to have helped many warriors become mothers after overcoming cancer, and to be part of these beautiful stories of resilience and love.

If you have been diagnosed with cancer, we hope this post has been helpful, and we encourage you to contact our clinic so that we can learn about your case and answer any questions you may have.

We are in this fight together, and we will be by your side so that your dream of becoming a mother can come true!

Get in touch to book your free first fertility consultation

Your first fertility appointment, free and personalised

If you have been trying to get pregnant for some time or have questions about what the next step is, at Clínica Fertia we help you from the first visit.